Olesen, Kevin Kris Warnakula http://orcid.org/0000-0002-0560-3615
Madsen, Morten
Gyldenkerne, Christine
Thrane, Pernille Gro
Thim, Troels
Jensen, Lisette Okkels
Bøtker, Hans Erik
Sørensen, Henrik Toft
Maeng, Michael
Funding for this research was provided by:
Department of Cardiology, Aarhus University Hospital
Article History
Received: 6 October 2020
Accepted: 1 January 2021
First Online: 21 January 2021
Ethics approval and consent to participate
: The study was approved by a regional branch of the Danish Data Protection Agency (record no. 1-16-02-193-18). Registry-based studies do not require approval from ethics committees or informed consent from participants according to Danish regulation.
: Informed consent is not required from participants in registry-based, non-interventional cohort studies according to Danish regulation.
: Dr. Olesen has received a speaking fee from Bayer. Dr. Thrane, Dr. Gyldenkerne, Dr. Thim, and Professor Bøtker have no conflicts of interest. Mr. Madsen and Professor Sørensen has not received any personal fees, grants, travel grants, or teaching grants from companies. Department of Clinical Epidemiology is, however, involved in studies with funding from various companies as research grants to and administered by Aarhus University. None of these studies are related to the current study. Professor Jensen has received unrestricted grants to Department of Cardiology Odense University Hospital from Biotronik and Biosensors. Dr. Maeng has received advisory board fees from Boehringer-Ingelheim, AstraZeneca, Novo Nordisk, BMS, Boston Scientific, and Bayer.